sheng pan
University of Texas Health Science Center at Houston
Houston, United States
Associate Editor
Molecular and Cellular Oncology
University of Texas Health Science Center at Houston
Houston, United States
Associate Editor
Molecular and Cellular Oncology
Peking University
Beijing, China
Associate Editor
Pharmacology of Anti-Cancer Drugs
Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University
Wuhan, China
Associate Editor
Cancer Molecular Targets and Therapeutics
Aristotle University of Thessaloniki
Thessaloniki, Greece
Associate Editor
Pediatric Oncology
Université de Montpellier
Montpellier, France
Associate Editor
Surgical Oncology
Segal Cancer Centre
Montreal, Canada
Associate Editor
Pharmacology of Anti-Cancer Drugs
Cooper Medical School of Rowan University
Camden, United States
Associate Editor
Molecular and Cellular Oncology
Magna Græcia University
Catanzaro, Italy
Associate Editor
Pharmacology of Anti-Cancer Drugs
University of Salerno
Fisciano, Italy
Associate Editor
Molecular and Cellular Oncology
University of Italian Switzerland
Lugano, Switzerland
Associate Editor
Gynecological Oncology
Aretaeio Hospital, National and Kapodistrian University of Athens
Athens, Greece
Associate Editor
Genitourinary Oncology
European University Cyprus
Engomi, Cyprus
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Bologna
Bologna, Italy
Associate Editor
Hematologic Malignancies
Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research
Parkville, Australia
Associate Editor
Cancer Immunity and Immunotherapy
2nd Department of Internal Medicine, University General Hospital Attikon
Athens, Greece
Associate Editor
Hematologic Malignancies
Department of Surgery, Medical School, Democritus University of Thrace
Xanthi, Greece
Associate Editor
Surgical Oncology